CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial
Product details
Registration number: SIN07168P
Classification: Prescription Only
Active ingredients: CLOXACILLIN SODIUM EQV CLOXACILLIN
Strength: 500 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: DUOPHARMA (SINGAPORE) PTE LTD
ATC code: J01CF02
HSA approval date: 8 October 1992
Manufacturer(s): LABORATOIRES PANPHARMA
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN07168P
Classification: Prescription Only
What active ingredients and strength are recorded for CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CLOXACILLIN SODIUM EQV CLOXACILLIN
Strength: 500 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: DUOPHARMA (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): LABORATOIRES PANPHARMA
Manufacturing country/countries: FRANCE
Where can I look up CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN07168P or the exact product name CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial. The general register link does not preselect this product.
What are the source dates for this CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CLOXACILLIN PANPHARMA FOR INJECTION 500 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN07168P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)